Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Teva Pharmaceutical Industries Ltd

NYSE: TEVA · Life Sciences · 11 alerts · CIK 818686

Share price
$42.57Close, Nov 16
Market cap
$49.7B
Shares outstanding
1.17BLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Teva Pharmaceutical Industries Ltd filings on SEC EDGAR ↗

4:16 PM ET Form 4
Insider Selling

Teva Pharmaceutical Industries EVP, Europe Commercial Richard Daniell Sells $1.93M of Stock

Richard Daniell, EVP, Europe Commercial, sold 45,003 shares of Teva Pharmaceutical Industries Ltd at $42.80 to $42.91 a share (average $42.86) in 2 transactions, worth $1.93M in total between Nov 9, 2026 and Nov 11, 2026. Shares held after the trade: 55,755 (-26.4%).

Value
$1.93M
Shares
45,003
Average price
$42.86
Role
EVP, Europe Commercial
Holding change
-26.4%
Trade date
Nov 9, 2026 to Nov 11, 2026
4:14 PM ET Form 4
Insider Selling

Teva Pharmaceutical Industries President and CEO Richard D. Francis Sells $10.6M of Stock

Richard D. Francis, President and CEO, sold 250,000 shares of Teva Pharmaceutical Industries Ltd at $42.24 a share, worth $10.6M in total on Nov 10, 2026. Shares held after the trade: 927,529 (-21.2%).

Value
$10.6M
Shares
250,000
Price
$42.24
Role
President and CEO
Holding change
-21.2%
Trade date
Nov 10, 2026
4:12 PM ET Form 4
Insider Selling

Teva Pharmaceutical Industries See "Remarks" Mark Sabag Sells $1.97M of Stock

Mark Sabag, See "Remarks", sold 44,710 shares of Teva Pharmaceutical Industries Ltd at $44.14 a share, worth $1.97M in total on Nov 12, 2026. Shares held after the trade: 80,760 (-35.6%).

Value
$1.97M
Shares
44,710
Price
$44.14
Role
See "Remarks"
Holding change
-35.6%
Trade date
Nov 12, 2026
4:11 PM ET Form 4
Insider Selling

Teva Pharmaceutical Industries CAO Amir Weiss Sells $744K of Stock

Amir Weiss, CAO, sold 17,289 shares of Teva Pharmaceutical Industries Ltd at $43.03 to $43.15 a share (average $43.04) in 3 transactions, worth $744K in total on Nov 9, 2026. Shares held after the trade: 3,537 (-72.9%).

Value
$744K
Shares
17,289
Average price
$43.04
Role
CAO
Holding change
-72.9%
Trade date
Nov 9, 2026
4:04 PM ET Form 4
Insider Selling

Teva Pharmaceutical Industries See "Remarks" Mark Sabag Sells $1.93M of Stock

Mark Sabag, See "Remarks", sold 46,000 shares of Teva Pharmaceutical Industries Ltd at $41.93 a share, worth $1.93M in total on Nov 5, 2026. Shares held after the trade: 80,760 (-36.3%).

Value
$1.93M
Shares
46,000
Price
$41.93
Role
See "Remarks"
Holding change
-36.3%
Trade date
Nov 5, 2026
4:02 PM ET Form 4
Insider Selling

Teva Pharmaceutical Industries Interim Cheif Legal Officer Dov Bergwerk Sells $1.1M of Stock

Dov Bergwerk, Interim Cheif Legal Officer, sold 26,260 shares of Teva Pharmaceutical Industries Ltd at $41.72 a share, worth $1.1M in total on Nov 4, 2026. Shares held after the trade: 11,943 (-42.3%).

Value
$1.1M
Shares
26,260
Average price
$41.72
Role
Interim Cheif Legal Officer
Holding change
-42.3%
Trade date
Nov 4, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.